No Data
No Data
Express News | Inovio Pharmaceuticals Inc - No Serious Adverse Events Identified in Retrospective Trial
Express News | Inovio Pharmaceuticals Inc - New Data to Inform Re-Dosing Strategy for Rrp Treatment
Express News | New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
INOVIO Reports Inducement Grant Under Inducement Plan
Trump Nominates Marty Makary For FDA Commissioner
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Unlock the Full List